Alyeska Investment Group
CNST

Alyeska Investment Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Alyeska Investment Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,616
Closed -$1.28M – 936
2020
Q4 		$1.28M Sell
44,616
-357
-0.8% -$8.99K 0.02% 403
2020
Q3 		$911K Buy
44,973
+25,000
+125% +$610K 0.01% 394
2020
Q2 		$600K Buy
+19,973
New +$719K 0.01% 431

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Alyeska Investment Group's CNST Position: Q1 2021 in Review

Alyeska Investment Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q1 2021, closing a stake of 44,616 shares — an estimated $1.28M sold.

Alyeska Investment Group first reported a position in CNST in Q2 2020 and held it in 3 quarters. The position peaked at $1.28M in Q4 2020. 131 funds tracked by Wall St. Rank hold CNST as of Q1 2021.

  • Alyeska Investment Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 44,616 Constellation Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1.28M.
  • Alyeska Investment Group first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 3 quarters.
  • Alyeska Investment Group's Constellation Pharmaceuticals, Inc. position peaked at $1.28M in Q4 2020.
  • 131 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.